GlobalData on MSN4mon
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPAThe trial assessed the efficacy and safety of Fasenra in line with mepolizumab, the only other approved treatment. Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback